SlideShare a Scribd company logo
Introduction to applied veterinary medicine
&
History taken
Karima Al Salihi
•Introduction
• Clinical examination of the
individual animal
A.History-taking
B.Examination of the
environment
C.Examination of the patient
Introduction
Definitions
!Veterinary medicine :The branch of medicine dealing with
the study, prevention, and treatment of diseases in animals,
especially domesticated animals.
!Veterinarians: A person suitably qualified and registered
to practice veterinary medicine and Also called veterinary
surgeon.
!Disease: It is inability to perform physiological functions
at normal levels even though nutrition and other
environmental requirements are provided at adequate
levels.
!Clinical signs: Recognizable clinical
signs such as fever, dyspnea,
convulsions or lameness that occurred in
individual food-producing animals and
horses, which are affected with a
particular, recognizable pathological
lesion, or biochemical or metabolic deficit,
or nutritional deficiency.
!Traditional veterinary medicine: It is 
based on a transposition of attitudes and
behaviour from human medicine.
Principles of Clinical examination of the individual
animal
• A clinical examination
has three parts:
• The history
• The animal
• The environment Clinical
examination
Animal
History The
environment
A. The history-taking•
In veterinary medicine, history-taking
is often the most important of the three
aspects of a clinical examination.
•Animals are unable to describe their clinical symptoms
•Dairy cattle, horses, sheep and goats are usually easy to
examine while beef cattle and pigs may be difficult to
examine adequately under some conditions.
•History-taking is an important key to accurate diagnosis
in veterinary medicine, and to be worthwhile it must be
accurate and complete.
History-taking method
•Establish veterinarian-client
relationship
•Asking the owner 'How can I help you
today?' It is an effective opening question,
which provides the owner the opportunity
to relate his or her concerns about the
animals(handled with diplomacy and tact)
and can use nontechnical terms.
•The clinician must try to separate owners'
observations from their interpretations.
•For completeness and accuracy in history-taking the clinician should
conform
to a set routine.
The system outlined below includes:
" patient data,
"Disease history
" management history.
•The order in which these parts of the history are taken will vary. In
general it is best to take the disease history first.
PATIENT DATA
•The relevant data include:
1.Owner's name and initials
2.Postal address and telephone number
3.Species, type, breed, Sex, age, name or number, body
weight
4. If necessary, a description, including
"colour markings,
"and other identifying marks, of the patient.
•Computers are now being
used extensively in
veterinary practices for
recording the details of farm
calls, the animals examined
and treated, the amounts
charged for travel and
professional services, the
costs of laboratory services,
the drugs used and
dispensed, and the diseases
that occur on a particular
farm on an ongoing basis.
Disease history
•History-taking will vary considerably
depending on:
" whether one animal or
" a group of animals,  is involved in the disease
problem under examination.
•As a general rule, in large animal work, all
disease states should be considered as herd
problems until proved to be otherwise.
•It is often rewarding to examine the remainder
of a group and find animals that are in the early
stages of the disease.
Disease history includes the following points:
Present disease

1.Means the clinical abnormalities observed by the owner in the sequence in
which they occurred. If more than one animal is affected, a typical case
should be chosen.
2.Variations from the normal in the physiological functions such as intake of
food or drink, milk production, growth, respiration, defecation, urination,
sweating, activity, gait, posture, voice and odor should be noted in all cases.
3.If a number of animals are affected, information may be available from
clinical pathological examinations carried out on living animals or necropsy
examinations on fatal cases.
4.The behaviour of animals before death and the period of time elapsing
between the first observable signs and death or recovery are important items
of information.
5.Prior surgical or medical procedures such as castration, docking, shearing,
or vaccination may be important factors in the production of disease.
Morbidity, case fatality and population
mortality rates
•The morbidity rate is usually expressed as the percentage of
animals that are
clinically affected compared with the total number of animals
exposed to the same risks.
•The case fatality rate is the percentage of affected animals that die.
•The population mortality rate is the percentage of all exposed
animals that die.
•The estimates may be important in diagnosis because of the
wide variations in morbidity, case fatality and population
mortality rates that occur in different diseases.
•An equally important figure is the proportion of animals at risk
that are clinically normal but show abnormality on the basis of
laboratory or other tests
•An equally
important figure
is the proportion
of animals at risk
that are clinically
normal but show
abnormality on
the basis of
laboratory or
other tests
Prior treatment
The owner may have treated animals
before calling for assistance (owners
reveal information about the drugs
that they have used).
•Exact details of the preparations used and doses
given may be of value in eliminating some diagnostic
possibilities.
•They will certainly be of importance when assessing
the probable efficiency of the treatment and the
significance of clinical pathological tests, and in
prescribing additional treatment.
•Drug withdrawal regulations now require that treated
animals or their products, such as milk, be withheld
from slaughter or market for varying lengths of time to
allow drug residues to reach tolerable limits.
Prophylactic and control
measures
•It should be ascertained whether preventive or
control procedures have already been attempted.
•There may have been clinical pathological tests,
the introduction of artificial insemination to
control venereal disease, vaccination, or
changes in nutrition, management or hygiene.
For example, in an outbreak of bovine mastitis
careful questioning should be pursued regarding
the method of disinfecting the cows' teats after
each milking, wit particular reference to the type
and concentration of the disinfectant used and
whether or not back-flushing of teat cups is
practiced
• Other things need to be know are:
• Previous exposure
• Culling rate
• Previous disease
• Management history
• Nutrition
• Reproductive management and
performance

More Related Content

What's hot

Putative role of pharmacist in reporting adr and contributing into the nation...
Putative role of pharmacist in reporting adr and contributing into the nation...Putative role of pharmacist in reporting adr and contributing into the nation...
Putative role of pharmacist in reporting adr and contributing into the nation...
Anindya Banerjee
 
Establishing a drug information center
Establishing a drug information centerEstablishing a drug information center
Establishing a drug information center
katta amulya
 
Adverse drug reactions ADRs by AKSHAY KUMAR
Adverse  drug  reactions ADRs by AKSHAY KUMARAdverse  drug  reactions ADRs by AKSHAY KUMAR
Adverse drug reactions ADRs by AKSHAY KUMAR
Akshaya Kumar
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmDDr.Sohel Memon
 
Pharmacovigilance methods
Pharmacovigilance methodsPharmacovigilance methods
Pharmacovigilance methods
Dr. Ramesh Bhandari
 
Clinical pharmacology
Clinical pharmacologyClinical pharmacology
Clinical pharmacology
جهاد الخريصي
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
PharmacologyMGM
 
Investigator brochure
Investigator brochureInvestigator brochure
Investigator brochure
kanchangupta66
 
Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,
Vishwajeet Upadhye
 
Essential drugs
Essential drugsEssential drugs
Essential drugs
Anagha Shende
 
Drug induced birth defect
Drug induced birth defectDrug induced birth defect
Drug induced birth defect
Dr. Ashish singh parihar
 
Pharmacovigilance: A Review
Pharmacovigilance: A ReviewPharmacovigilance: A Review
Pharmacovigilance: A Review
Mahewash Sana Pathan
 
Vaccine safety surveillance
Vaccine safety surveillanceVaccine safety surveillance
Vaccine safety surveillance
Dr Priyanka Goswami
 
An overview of the New Drug Discovery & Development Process
An overview of the New Drug Discovery & Development ProcessAn overview of the New Drug Discovery & Development Process
An overview of the New Drug Discovery & Development Process
HrushikeshVelis
 
Clinical Trials & its phases.
Clinical Trials & its phases.Clinical Trials & its phases.
Clinical Trials & its phases.
Raghav Sharma
 
SAE Narrative Writing
SAE Narrative WritingSAE Narrative Writing
SAE Narrative Writing
Fernanda de Lima Ferreira
 
DASARI NIROOSHA
DASARI NIROOSHADASARI NIROOSHA
DASARI NIROOSHA
Ramesh Ganpisetti
 
ADR Pharmacist Reporting
ADR Pharmacist ReportingADR Pharmacist Reporting
ADR Pharmacist ReportingRishi Kumar
 

What's hot (20)

Putative role of pharmacist in reporting adr and contributing into the nation...
Putative role of pharmacist in reporting adr and contributing into the nation...Putative role of pharmacist in reporting adr and contributing into the nation...
Putative role of pharmacist in reporting adr and contributing into the nation...
 
Basics Of Pharmacovigilance
Basics Of PharmacovigilanceBasics Of Pharmacovigilance
Basics Of Pharmacovigilance
 
Establishing a drug information center
Establishing a drug information centerEstablishing a drug information center
Establishing a drug information center
 
Adverse drug reactions ADRs by AKSHAY KUMAR
Adverse  drug  reactions ADRs by AKSHAY KUMARAdverse  drug  reactions ADRs by AKSHAY KUMAR
Adverse drug reactions ADRs by AKSHAY KUMAR
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
 
Pharmacovigilance methods
Pharmacovigilance methodsPharmacovigilance methods
Pharmacovigilance methods
 
Clinical pharmacology
Clinical pharmacologyClinical pharmacology
Clinical pharmacology
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Investigator brochure
Investigator brochureInvestigator brochure
Investigator brochure
 
Spontaneous reporting
Spontaneous reporting Spontaneous reporting
Spontaneous reporting
 
Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,Spontaneous reporting schemes for biodrug adverse reactions,
Spontaneous reporting schemes for biodrug adverse reactions,
 
Essential drugs
Essential drugsEssential drugs
Essential drugs
 
Drug induced birth defect
Drug induced birth defectDrug induced birth defect
Drug induced birth defect
 
Pharmacovigilance: A Review
Pharmacovigilance: A ReviewPharmacovigilance: A Review
Pharmacovigilance: A Review
 
Vaccine safety surveillance
Vaccine safety surveillanceVaccine safety surveillance
Vaccine safety surveillance
 
An overview of the New Drug Discovery & Development Process
An overview of the New Drug Discovery & Development ProcessAn overview of the New Drug Discovery & Development Process
An overview of the New Drug Discovery & Development Process
 
Clinical Trials & its phases.
Clinical Trials & its phases.Clinical Trials & its phases.
Clinical Trials & its phases.
 
SAE Narrative Writing
SAE Narrative WritingSAE Narrative Writing
SAE Narrative Writing
 
DASARI NIROOSHA
DASARI NIROOSHADASARI NIROOSHA
DASARI NIROOSHA
 
ADR Pharmacist Reporting
ADR Pharmacist ReportingADR Pharmacist Reporting
ADR Pharmacist Reporting
 

Similar to 1 introduction to applied veterinary medicine

History taking of animals
History taking of animalsHistory taking of animals
History taking of animals
Dr. Muhammad Awais
 
Powerpoint final
Powerpoint finalPowerpoint final
Powerpoint finalemm_22
 
Epidemiological intelligence
Epidemiological intelligenceEpidemiological intelligence
Epidemiological intelligence
DrRadhakrishna Sahu
 
qaqaqa.pptx
qaqaqa.pptxqaqaqa.pptx
qaqaqa.pptx
ssuserc8c2e2
 
Quarantine and Health Screening Protocols.pdf
Quarantine and Health Screening Protocols.pdfQuarantine and Health Screening Protocols.pdf
Quarantine and Health Screening Protocols.pdf
AnwarKhan240
 
Ethics of Using animals in Research
Ethics of Using animals in ResearchEthics of Using animals in Research
Ethics of Using animals in Research
Rabie Fayed
 
cpcsea guidelines for laboratory animal facility-pptx
cpcsea guidelines for laboratory animal facility-pptxcpcsea guidelines for laboratory animal facility-pptx
cpcsea guidelines for laboratory animal facility-pptx
ANIKETH SURVE
 
CPCSEA guidelines ppt
CPCSEA guidelines pptCPCSEA guidelines ppt
CPCSEA guidelines ppt
DhruviParmar
 
History Taking.pptx
History Taking.pptxHistory Taking.pptx
History Taking.pptx
Rameshjoshi66
 
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
John Blue
 
RCT CH1.ppt
RCT CH1.pptRCT CH1.ppt
RCT CH1.ppt
AbebeNega
 
Surveillance
Surveillance Surveillance
Surveillance
Perez Eric
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
NESIHHN
 
Animal models in toxicological studies
Animal models in toxicological studiesAnimal models in toxicological studies
Animal models in toxicological studies
Dr. Sindhu K., Asst. Prof., Dept. of VPT, VCG.
 
Pharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptxPharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptx
abhiirode
 
Lecture 10 : Animal Diseases
Lecture 10 : Animal DiseasesLecture 10 : Animal Diseases
Lecture 10 : Animal Diseases
WiseAcademy
 
Overview of public health
Overview of public healthOverview of public health
Overview of public health
karked
 
Medication Administration and Calculation for Nurses Returning to Practice
Medication Administration and Calculation for Nurses Returning to PracticeMedication Administration and Calculation for Nurses Returning to Practice
Medication Administration and Calculation for Nurses Returning to Practice
IHNA Australia
 
patient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxpatient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptx
MansoorKhan22677
 

Similar to 1 introduction to applied veterinary medicine (20)

History taking of animals
History taking of animalsHistory taking of animals
History taking of animals
 
Powerpoint final
Powerpoint finalPowerpoint final
Powerpoint final
 
Epidemiological intelligence
Epidemiological intelligenceEpidemiological intelligence
Epidemiological intelligence
 
qaqaqa.pptx
qaqaqa.pptxqaqaqa.pptx
qaqaqa.pptx
 
Quarantine and Health Screening Protocols.pdf
Quarantine and Health Screening Protocols.pdfQuarantine and Health Screening Protocols.pdf
Quarantine and Health Screening Protocols.pdf
 
Ethics of Using animals in Research
Ethics of Using animals in ResearchEthics of Using animals in Research
Ethics of Using animals in Research
 
cpcsea guidelines for laboratory animal facility-pptx
cpcsea guidelines for laboratory animal facility-pptxcpcsea guidelines for laboratory animal facility-pptx
cpcsea guidelines for laboratory animal facility-pptx
 
CPCSEA guidelines ppt
CPCSEA guidelines pptCPCSEA guidelines ppt
CPCSEA guidelines ppt
 
History Taking.pptx
History Taking.pptxHistory Taking.pptx
History Taking.pptx
 
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
 
RCT CH1.ppt
RCT CH1.pptRCT CH1.ppt
RCT CH1.ppt
 
Surveillance
Surveillance Surveillance
Surveillance
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Animal models in toxicological studies
Animal models in toxicological studiesAnimal models in toxicological studies
Animal models in toxicological studies
 
Pharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptxPharmacology Laboratory Animals.pptx
Pharmacology Laboratory Animals.pptx
 
Chemo2
Chemo2Chemo2
Chemo2
 
Lecture 10 : Animal Diseases
Lecture 10 : Animal DiseasesLecture 10 : Animal Diseases
Lecture 10 : Animal Diseases
 
Overview of public health
Overview of public healthOverview of public health
Overview of public health
 
Medication Administration and Calculation for Nurses Returning to Practice
Medication Administration and Calculation for Nurses Returning to PracticeMedication Administration and Calculation for Nurses Returning to Practice
Medication Administration and Calculation for Nurses Returning to Practice
 
patient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxpatient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptx
 

More from karima Akool AlSalihi

8 dermatology (skin diseases)
8 dermatology(skin diseases)8 dermatology(skin diseases)
8 dermatology (skin diseases)
karima Akool AlSalihi
 
5 diseases of the lung pneumonia
5 diseases of the lung   pneumonia 5 diseases of the lung   pneumonia
5 diseases of the lung pneumonia
karima Akool AlSalihi
 
16 copper deficiency and associated diseases part 2
16 copper deficiency andassociated diseases part 216 copper deficiency andassociated diseases part 2
16 copper deficiency and associated diseases part 2
karima Akool AlSalihi
 
19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins 19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins
karima Akool AlSalihi
 
18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency 18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency
karima Akool AlSalihi
 
17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies
karima Akool AlSalihi
 
15 copper deficiency part 1
15 copper deficiency part 115 copper deficiency part 1
15 copper deficiency part 1
karima Akool AlSalihi
 
14 deficiency of trace elements
14 deficiency of trace elements 14 deficiency of trace elements
14 deficiency of trace elements
karima Akool AlSalihi
 
13 osteomalacia
13 osteomalacia13 osteomalacia
13 osteomalacia
karima Akool AlSalihi
 
12 introduction to nutritional deficincies
12 introduction to nutritional deficincies 12 introduction to nutritional deficincies
12 introduction to nutritional deficincies
karima Akool AlSalihi
 
13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals
karima Akool AlSalihi
 
12 examination of the udder
12 examination of the udder 12 examination of the udder
12 examination of the udder
karima Akool AlSalihi
 
10 clinical examination lymph nodes
10 clinical examination lymph nodes  10 clinical examination lymph nodes
10 clinical examination lymph nodes
karima Akool AlSalihi
 
12 examination of the urogenital system
12 examination of the urogenital system12 examination of the urogenital system
12 examination of the urogenital system
karima Akool AlSalihi
 
29 june 2020 clinical case
29 june 2020 clinical case 29 june 2020 clinical case
29 june 2020 clinical case
karima Akool AlSalihi
 
Bovine theileriosis
Bovine theileriosisBovine theileriosis
Bovine theileriosis
karima Akool AlSalihi
 
28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis
karima Akool AlSalihi
 
27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case
karima Akool AlSalihi
 
9 examination of digestive system
9 examination of digestive system 9 examination of digestive system
9 examination of digestive system
karima Akool AlSalihi
 
8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals
karima Akool AlSalihi
 

More from karima Akool AlSalihi (20)

8 dermatology (skin diseases)
8 dermatology(skin diseases)8 dermatology(skin diseases)
8 dermatology (skin diseases)
 
5 diseases of the lung pneumonia
5 diseases of the lung   pneumonia 5 diseases of the lung   pneumonia
5 diseases of the lung pneumonia
 
16 copper deficiency and associated diseases part 2
16 copper deficiency andassociated diseases part 216 copper deficiency andassociated diseases part 2
16 copper deficiency and associated diseases part 2
 
19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins 19 vitamin a deficiency: deficiency of fat soluble vitamins
19 vitamin a deficiency: deficiency of fat soluble vitamins
 
18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency 18 selenium and:or vitamin e deficiency
18 selenium and:or vitamin e deficiency
 
17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies17 zinc,cobalt, iodine deficiencies
17 zinc,cobalt, iodine deficiencies
 
15 copper deficiency part 1
15 copper deficiency part 115 copper deficiency part 1
15 copper deficiency part 1
 
14 deficiency of trace elements
14 deficiency of trace elements 14 deficiency of trace elements
14 deficiency of trace elements
 
13 osteomalacia
13 osteomalacia13 osteomalacia
13 osteomalacia
 
12 introduction to nutritional deficincies
12 introduction to nutritional deficincies 12 introduction to nutritional deficincies
12 introduction to nutritional deficincies
 
13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals13 clinical examination of skin and appendages in animals
13 clinical examination of skin and appendages in animals
 
12 examination of the udder
12 examination of the udder 12 examination of the udder
12 examination of the udder
 
10 clinical examination lymph nodes
10 clinical examination lymph nodes  10 clinical examination lymph nodes
10 clinical examination lymph nodes
 
12 examination of the urogenital system
12 examination of the urogenital system12 examination of the urogenital system
12 examination of the urogenital system
 
29 june 2020 clinical case
29 june 2020 clinical case 29 june 2020 clinical case
29 june 2020 clinical case
 
Bovine theileriosis
Bovine theileriosisBovine theileriosis
Bovine theileriosis
 
28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis28 june 2020 reticuloperitonitis
28 june 2020 reticuloperitonitis
 
27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case27 june 2020 , bovine clinical case
27 june 2020 , bovine clinical case
 
9 examination of digestive system
9 examination of digestive system 9 examination of digestive system
9 examination of digestive system
 
8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals8 clinical examination of cardiovascular system in animals
8 clinical examination of cardiovascular system in animals
 

Recently uploaded

Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
zeex60
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
yqqaatn0
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
sanjana502982
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills MN
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 
20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx
Sharon Liu
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 

Recently uploaded (20)

Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Introduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptxIntroduction to Mean Field Theory(MFT).pptx
Introduction to Mean Field Theory(MFT).pptx
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
原版制作(carleton毕业证书)卡尔顿大学毕业证硕士文凭原版一模一样
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Toxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and ArsenicToxic effects of heavy metals : Lead and Arsenic
Toxic effects of heavy metals : Lead and Arsenic
 
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 
20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 

1 introduction to applied veterinary medicine

  • 1. Introduction to applied veterinary medicine & History taken Karima Al Salihi
  • 2. •Introduction • Clinical examination of the individual animal A.History-taking B.Examination of the environment C.Examination of the patient
  • 3. Introduction Definitions !Veterinary medicine :The branch of medicine dealing with the study, prevention, and treatment of diseases in animals, especially domesticated animals. !Veterinarians: A person suitably qualified and registered to practice veterinary medicine and Also called veterinary surgeon. !Disease: It is inability to perform physiological functions at normal levels even though nutrition and other environmental requirements are provided at adequate levels.
  • 4. !Clinical signs: Recognizable clinical signs such as fever, dyspnea, convulsions or lameness that occurred in individual food-producing animals and horses, which are affected with a particular, recognizable pathological lesion, or biochemical or metabolic deficit, or nutritional deficiency. !Traditional veterinary medicine: It is  based on a transposition of attitudes and behaviour from human medicine.
  • 5. Principles of Clinical examination of the individual animal • A clinical examination has three parts: • The history • The animal • The environment Clinical examination Animal History The environment
  • 6. A. The history-taking• In veterinary medicine, history-taking is often the most important of the three aspects of a clinical examination. •Animals are unable to describe their clinical symptoms •Dairy cattle, horses, sheep and goats are usually easy to examine while beef cattle and pigs may be difficult to examine adequately under some conditions. •History-taking is an important key to accurate diagnosis in veterinary medicine, and to be worthwhile it must be accurate and complete.
  • 7. History-taking method •Establish veterinarian-client relationship •Asking the owner 'How can I help you today?' It is an effective opening question, which provides the owner the opportunity to relate his or her concerns about the animals(handled with diplomacy and tact) and can use nontechnical terms. •The clinician must try to separate owners' observations from their interpretations.
  • 8. •For completeness and accuracy in history-taking the clinician should conform to a set routine. The system outlined below includes: " patient data, "Disease history " management history. •The order in which these parts of the history are taken will vary. In general it is best to take the disease history first.
  • 9. PATIENT DATA •The relevant data include: 1.Owner's name and initials 2.Postal address and telephone number 3.Species, type, breed, Sex, age, name or number, body weight 4. If necessary, a description, including "colour markings, "and other identifying marks, of the patient.
  • 10.
  • 11. •Computers are now being used extensively in veterinary practices for recording the details of farm calls, the animals examined and treated, the amounts charged for travel and professional services, the costs of laboratory services, the drugs used and dispensed, and the diseases that occur on a particular farm on an ongoing basis.
  • 12. Disease history •History-taking will vary considerably depending on: " whether one animal or " a group of animals,  is involved in the disease problem under examination. •As a general rule, in large animal work, all disease states should be considered as herd problems until proved to be otherwise. •It is often rewarding to examine the remainder of a group and find animals that are in the early stages of the disease.
  • 13. Disease history includes the following points: Present disease
 1.Means the clinical abnormalities observed by the owner in the sequence in which they occurred. If more than one animal is affected, a typical case should be chosen. 2.Variations from the normal in the physiological functions such as intake of food or drink, milk production, growth, respiration, defecation, urination, sweating, activity, gait, posture, voice and odor should be noted in all cases. 3.If a number of animals are affected, information may be available from clinical pathological examinations carried out on living animals or necropsy examinations on fatal cases. 4.The behaviour of animals before death and the period of time elapsing between the first observable signs and death or recovery are important items of information. 5.Prior surgical or medical procedures such as castration, docking, shearing, or vaccination may be important factors in the production of disease.
  • 14. Morbidity, case fatality and population mortality rates •The morbidity rate is usually expressed as the percentage of animals that are clinically affected compared with the total number of animals exposed to the same risks. •The case fatality rate is the percentage of affected animals that die. •The population mortality rate is the percentage of all exposed animals that die. •The estimates may be important in diagnosis because of the wide variations in morbidity, case fatality and population mortality rates that occur in different diseases. •An equally important figure is the proportion of animals at risk that are clinically normal but show abnormality on the basis of laboratory or other tests
  • 15. •An equally important figure is the proportion of animals at risk that are clinically normal but show abnormality on the basis of laboratory or other tests
  • 16. Prior treatment The owner may have treated animals before calling for assistance (owners reveal information about the drugs that they have used). •Exact details of the preparations used and doses given may be of value in eliminating some diagnostic possibilities. •They will certainly be of importance when assessing the probable efficiency of the treatment and the significance of clinical pathological tests, and in prescribing additional treatment. •Drug withdrawal regulations now require that treated animals or their products, such as milk, be withheld from slaughter or market for varying lengths of time to allow drug residues to reach tolerable limits.
  • 17. Prophylactic and control measures •It should be ascertained whether preventive or control procedures have already been attempted. •There may have been clinical pathological tests, the introduction of artificial insemination to control venereal disease, vaccination, or changes in nutrition, management or hygiene. For example, in an outbreak of bovine mastitis careful questioning should be pursued regarding the method of disinfecting the cows' teats after each milking, wit particular reference to the type and concentration of the disinfectant used and whether or not back-flushing of teat cups is practiced
  • 18. • Other things need to be know are: • Previous exposure • Culling rate • Previous disease • Management history • Nutrition • Reproductive management and performance